WallStreetZenWallStreetZen

NASDAQ: RYTM
Rhythm Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RYTM

Based on 11 analysts offering 12 month price targets for Rhythm Pharmaceuticals Inc

Min Forecast
$105.00-2.81%
Avg Forecast
$141.09+30.59%
Max Forecast
$155.00+43.47%

Should I buy or sell RYTM stock?

Based on 11 analysts offering ratings for Rhythm Pharmaceuticals Inc.

Strong Buy
Strong Buy
7 analysts 63.64%
Buy
4 analysts 36.36%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RYTM's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates RYTM as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their RYTM stock forecasts and price targets.

RYTM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-07-27
lockedlocked$00.00+00.00%2026-07-07
lockedlocked$00.00+00.00%2026-06-16Find Out Why
lockedlocked$00.00+00.00%2026-06-15Find Out Why
lockedlocked$00.00+00.00%2026-03-23
Citigroup
Top 17%
84
Strong BuyMaintains$142.00+31.43%2026-03-20
Bank of America
Top 25%
76
Strong BuyMaintains$149.00+37.91%2026-03-20
Citizens
Top 2%
99
BuyMaintains$155.00+43.47%2026-03-20
Morgan Stanley
Top 6%
95
Strong BuyMaintains$136.00+25.88%2026-03-17
Needham
Top 2%
99
BuyMaintains$130.00+20.33%2026-03-17

1 of 2

Forecast return on equity

Is RYTM forecast to generate an efficient return?

Company
404.38%
Industry
91.73%
Market
174.76%
RYTM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RYTM forecast to generate an efficient return on assets?

Company
112.37%
Industry
27.17%
RYTM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RYTM earnings per share forecast

What is RYTM's earnings per share in the next 3 years based on estimates from 18 analysts?

Avg 1 year Forecast
-$3.24
Avg 2 year Forecast
-$0.65
Avg 3 year Forecast
$3.07

RYTM revenue forecast

What is RYTM's revenue in the next 3 years based on estimates from 18 analysts?

Avg 1 year Forecast
$304.9M+40.4%
Avg 2 year Forecast
$554.0M+155.11%
Avg 3 year Forecast
$893.6M+311.48%
RYTM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RYTM revenue growth forecast

How is RYTM forecast to perform vs Biotechnology companies and vs the US market?

Company
59.06%
Industry
34.63%
Market
13.75%
RYTM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RYTM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RYTM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RYTM$108.04$141.09+30.59%Strong Buy
IBRX$6.97$15.50+122.38%Strong Buy
LQDA$86.82$78.17-9.97%Buy
COGT$40.67$54.25+33.39%Strong Buy
PCVX$54.60$102.50+87.73%Strong Buy
View Top Biotech Stocks

Rhythm Pharmaceuticals Stock Forecast FAQ

Is Rhythm Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: RYTM) stock is to Strong Buy RYTM stock.

Out of 11 analysts, 7 (63.64%) are recommending RYTM as a Strong Buy, 4 (36.36%) are recommending RYTM as a Buy, 0 (0%) are recommending RYTM as a Hold, 0 (0%) are recommending RYTM as a Sell, and 0 (0%) are recommending RYTM as a Strong Sell.

If you're new to stock investing, here's how to buy Rhythm Pharmaceuticals stock.

What is RYTM's earnings growth forecast for 2026-2028?

(NASDAQ: RYTM) Rhythm Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 17.05%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.99%.

Rhythm Pharmaceuticals's earnings in 2026 is -$207,840,000.On average, 18 Wall Street analysts forecast RYTM's earnings for 2026 to be -$221,888,022, with the lowest RYTM earnings forecast at -$260,588,385, and the highest RYTM earnings forecast at -$176,300,132. On average, 18 Wall Street analysts forecast RYTM's earnings for 2027 to be -$44,662,700, with the lowest RYTM earnings forecast at -$173,545,121, and the highest RYTM earnings forecast at $84,911,900.

In 2028, RYTM is forecast to generate $210,168,946 in earnings, with the lowest earnings forecast at $102,086,171 and the highest earnings forecast at $441,110,125.

What is RYTM's revenue growth forecast for 2026-2028?

(NASDAQ: RYTM) Rhythm Pharmaceuticals's forecast annual revenue growth rate of 59.06% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.75%.

Rhythm Pharmaceuticals's revenue in 2026 is $217,165,000.On average, 18 Wall Street analysts forecast RYTM's revenue for 2026 to be $20,894,906,548, with the lowest RYTM revenue forecast at $18,374,277,263, and the highest RYTM revenue forecast at $23,098,915,189. On average, 18 Wall Street analysts forecast RYTM's revenue for 2027 to be $37,967,749,604, with the lowest RYTM revenue forecast at $29,215,450,364, and the highest RYTM revenue forecast at $46,557,626,565.

In 2028, RYTM is forecast to generate $61,240,052,289 in revenue, with the lowest revenue forecast at $43,655,270,659 and the highest revenue forecast at $82,924,454,470.

What is RYTM's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: RYTM) forecast ROA is 112.37%, which is higher than the forecast US Biotechnology industry average of 27.17%.

What is RYTM's Price Target?

According to 11 Wall Street analysts that have issued a 1 year RYTM price target, the average RYTM price target is $141.09, with the highest RYTM stock price forecast at $155.00 and the lowest RYTM stock price forecast at $105.00.

On average, Wall Street analysts predict that Rhythm Pharmaceuticals's share price could reach $141.09 by Jul 27, 2027. The average Rhythm Pharmaceuticals stock price prediction forecasts a potential upside of 30.59% from the current RYTM share price of $108.04.

What is RYTM's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: RYTM) Rhythm Pharmaceuticals's current Earnings Per Share (EPS) is -$3.13. On average, analysts forecast that RYTM's EPS will be -$3.24 for 2026, with the lowest EPS forecast at -$3.80, and the highest EPS forecast at -$2.57. On average, analysts forecast that RYTM's EPS will be -$0.65 for 2027, with the lowest EPS forecast at -$2.53, and the highest EPS forecast at $1.24. In 2028, RYTM's EPS is forecast to hit $3.07 (min: $1.49, max: $6.44).

What is RYTM's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: RYTM) forecast ROE is 404.38%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.